Form 4 for CVS CVS Health
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-08 · accession 0001127602-22-011910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-12 | 2022-04-08 | CVS | Shah Prem S | EVP, Co-Pres of Retail | M - OptEx | $62.37 | +13.8K | 50.7K | +38% | +$862.1K |
| DM | 2022-04-12 | 2022-04-08 | CVS | Shah Prem S | EVP, Co-Pres of Retail | S - Sale+OE | $105.00 | -17.0K | 46.6K | -27% | -$1.78M |
| DM | 2022-04-12 | 2022-04-08 | CVS | Shah Prem S | EVP, Co-Pres of Retail | M - OptEx | $0.00 | -13.8K | 28.7K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-08 | M | A | 3,157 | $54.19 | 49,740.24 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-08 | S | D | 3,130 | $105.00 | 43,453.24 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-08 | S | D | 4,103 | $105.00 | 46,583.24 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-08 | M | A | 845 | $62.21 | 47,428.24 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-08 | S | D | 845 | $105.00 | 46,583.24 | D | — | — | |
| 6 | Common | Common Stock | 2022-04-08 | S | D | 3,157 | $105.00 | 46,583.24 | D | — | — | |
| 7 | Common | Common Stock | 2022-04-08 | M | A | 5,719 | $58.34 | 52,302.24 | D | — | — | |
| 8 | Common | Common Stock | 2022-04-08 | S | D | 5,719 | $105.00 | 46,583.24 | D | — | — | |
| 9 | Common | Common Stock | 2022-04-08 | M | A | 4,103 | $74.30 | 50,686.24 | D | — | — | |
| 10 | Derivative | Stock Option | 2022-04-08 | M | D | 5,719 | $0.00 | 28,596 | D | $58.34 · 2021-04-01 to 2030-04-01 | 5,719 Common Stock | (F7) Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised. |
| 11 | Derivative | Stock Option | 2022-04-08 | M | D | 845 | $0.00 | 846 | D | $62.21 · 2019-04-01 to 2025-04-01 | 845 Common Stock | (F5) Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised. |
| 12 | Derivative | Stock Option | 2022-04-08 | M | D | 3,157 | $0.00 | 9,469 | D | $54.19 · 2020-04-01 to 2029-04-01 | 3,157 Common Stock | (F6) Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised. |
| 13 | Derivative | Stock Option | 2022-04-08 | M | D | 4,103 | $0.00 | 28,723 | D | $74.30 · 2022-04-01 to 2031-04-01 | 4,103 Common Stock | (F8) Option becomes exercisable in three equal installments commencing 04/01/2022. |